UNICEF Update
IPC Meeting
Geneva, 22 – 23 June 2017
UNICEF expenditure (2016, by major material groups)
• 81% of UNICEF procurement is in collaboration with other
UN agencies and Partners($2.858 billion)
$1.73 billion in procurement on behalf of 80 self-financing governments and partners
$3.519 billion of supplies + services for 147 countries and areas
Vaccines
$1.643 billion
100%
Gavi, BMGF, WHO, PAHO MSF, CDC
Nutrition
$150.6 million
100%
WHO, WFP,, MSF, CIFF
Bed nets &
insect.
$90.7 million
100% WHO, UNFPA, UNDP, GFATM UNITAID
Water &
sanitation
$108.2 million
30% WHO, Oxfam, SAVE, UNHCR
Pharmaceuticals
$160.6 million
100%
WHO, UNFPA, UNDP, GFATM UNITAID, CHAI, MSF
Education
$83.8 million
30%
SAVE, WB
Medical supplies
$138.7 million
95%
WHO, UNFPA, UNDP, GFATM UNITAID, CHAI, MSF, CDC
$2.637 billion supplies $882 million services
Supplier Countries 2016
Countries where
UNICEF supplies were used
Cumulative savings from 2012 to date > $1.5 billion
Savings by Commodity
Global Emergency Activities
Ready to Use Therapeutic Food
0
10
20
30
40
50
60
70
80
0
5,000
10,000
15,000
20,000
25,000
30,000
35,000
40,000
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 6Jun17
Num
ber
o
f C
ountr
ies
Sup
pli
ed
Ther
apeu
tic
Foods
in
MT
Forecast RUTF Biscuit RUTF Paste Country Recipients
Global & Local warehousing & transport
$114.4 million value of
throughput
25 %
of outgoing orders
were for emergency
response
241,976 kits packed and
shipped
The Global Supply Warehouse
- Largest
humanitarian
warehouse
- Highly automated
- Hazards & GDP
certified
SD managed warehouses – 2016
$114.4 million value of throughput
241,976 kits packed and shipped
Dubai: nutrition, natural disasters
Shanghai: Education kits
Panama: serves LAC, natural disasters
Djibouti: serves Yemen
Kit-packing targets
Reduce lead-time (3 million items)
Health kit-packing in Africa & India
Access to Vaccine for Use in Humanitarian Crisis: Progress to Date
• A “Humanitarian Mechanism” has been developed by WHO, UNICEF, MSF, & Save the Children to enable CSOs, governments and UN agencies access affordable vaccine for use in humanitarian emergencies
• The mechanism is finalized and available as of 1 May 2017: http://www.who.int/immunization/programmes_systems/sustainability/The_Humanitarian_Mechanism_ToRs.pdf?ua=1
• Two offers have been made for Pneumococcal conjugate vaccines, for making PCV vaccine available at Gavi prices, for use in Humanitarian context including securing access for CSOs
• UNICEF has made long term supply arrangements for access to these offers
• 124,000 ds of PCV vaccines have been shipped for support to refugees through a donation from one manufacturer in January 2017
Medecines: some figures
Antiretrovirals (ARVs) 2016: 6.1 M packs of ARVs procured. Equivalent treatment for an estimated 394,529 adult patients for one year of first-line therapy in 37 countries Amoxicillin DT 2014: 8.5 M pneumonia treatments 2016: 32.2 M pneumonia treatments. Supply to 34 countries ORS-Zinc Co-Pack 2014: 1.8 M packs 2016: 13.4 M packs (sources in India, Bangladesh, Kenya and Nigeria) Malaria Prevention 2016: 10.6 Million SMC treatements, 9.6 M courses of SP
Polio cessation and 2017 UNICEF work priorities
• Ensuring coordinated and efficient supply and delivery of polio vaccines to countries
• IPV procurement: Procurement strategy, tender, partner consultation, awards, contracting for supply from 2019 and beyond
• OPV procurement: Tender, awards, partner consultation, contracting to secure supply from 2018 through cessation, including consultations with GPEI senior management on supply risk mitigation options and funding requirements
• OPV global stockpiles – maintain and extend current existing stocks of bulk and mOPV2 for outbreak response
Malaria Prevention and Diagnostics Key Projects
LLINs Major Projects: • 15.7 m LLINs to Côte d'Ivoire (US$ 44 million) – 497 containers (Delivery in progress)
• 6 m LLINs to Chad (US$ 12.6 million) – 172 containers (Delivery in progress)
• 6.0 m LLINs to Sudan (US$ 12.6 million) – 148 Containers (Delivery in progress)
• 1.2 m LLINs to Afghanistan – (US$ 3 million)
ZIKA Virus R&D Diagnostics • Developed target product profiles (TPPs) for ZIKV IVD to guide industry
• Developed an innovative financial tool (Advanced Purchase Commitment)
• Demand forecasts have been defined, shared with industry
• Launched the first tender in February 2017
HIV PoC VL EID Diagnostics • HIV Diagnostics at PoC: Early Infant Diagnosis (EID), and Viral Load (VL)
• Funded by UNITAID - support the Point of Care (POC) HIV diagnostics market for accelerated scale up in 10 countries
• Phase 1 approved in December 2012 for a period of one year - $20 million
• Phase 2a approved in December 2013 for a period of 18 months - $35 million
• Phase 2b approved in September 2016 for a period of 4 years - $95 millions
Country Capacity Building in Planning and Procurement of Vaccines, Medicines and Devices
• Procurement Practitioners Forums on Vaccines and Medicines
• Country-specific support on vaccine procurement planning and implementation
• Gavi/GF transitioning country support
© U
NIC
EF
/SU
DA
2014
-XX
22
8/N
oora
ni
Thank You
17